Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Critical Outcome Technologies reports promising preclinical data on COTI-2

Oct. 21, 2011

OncoGenex Pharmaceuticals begins enrollment in OGX-427 study

Oct. 21, 2011

Novel nitroxyl-releasing agents synthesized in U.S.

Oct. 21, 2011

Kinagen claims new protein kinase inhibitors

Oct. 21, 2011

Further phase I data reported on GDC-941 in metastatic and advanced cancer

Oct. 21, 2011

Analysis of TIRASMUS data identifies possible marker of temsirolimus efficacy in colorectal cancer

Oct. 21, 2011

German research team presents new cyclin-dependent kinase 9 inhibitors

Oct. 21, 2011

FDA opens Cleveland BioLabs' IND for CBLB-502

Oct. 20, 2011

Viralytics begins enrollment in phase II Cavatak trial following approval for dosing

Oct. 20, 2011

New protein kinase inhibitors presented by GSK

Oct. 20, 2011

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...